Author

Jennifer Xu

Observed name: J Xu

Institutions: University of California, Irvine, University of California System

Observed institutions: University of California, Irvine, Liverpool Hospital, University of California System, UNSW Sydney

ORCID: 0009-0006-1462-4529

Observed ORCID: 0009-0006-1462-4529

OpenAlex ID: A5080246203

Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with Malassezia-specific immunoglobulin E levels mirroring clinical response

2022 · Emily Kozera, Akshay Flora, et al. · Journal of the American Academy of Dermatology · 23

The impact of psoriasis biologic therapy on HIV viral load and CD4 + cell counts in HIV ‐positive individuals: A real‐world cohort study

2023 · Jennifer Xu, Kyra Gill, et al. · Journal of the European Academy of Dermatology and Venereology · 19

Baseline clinical, hormonal and molecular markers associated with clinical response to IL ‐23 antagonism in hidradenitis suppurativa: A prospective cohort study

2023 · A Flora, EK Kozera, et al. · Experimental Dermatology · 11

Strongyloides screening prior to dupilumab therapy in atopic dermatitis: a retrospective cohort study evaluating screening utility

2022 · Kyra Gill, Jennifer Xu, et al. · British Journal of Dermatology · 5

Running the risk: Extreme right ventricular remodeling in an endurance athlete — a case report

2025 · Jonathan S Ahn, Elizabeth H Dineen, et al. · European Heart Journal - Case Reports

Works count: 5

Citation count: 58

H-index: 4

I10-index: 3